Page last updated: 2024-08-24

triazoles and sphingosine kinase

triazoles has been researched along with sphingosine kinase in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anthony, NG; Baek, DJ; Bittman, R; Mackay, SP; MacRitchie, N; Pyne, NJ; Pyne, S1
Bianco, R; Caliendo, G; Ciciola, P; Cirino, G; Corvino, A; Fiorino, F; Frecentese, F; Incisivo, GM; Magli, E; Perissutti, E; Riemma, MA; Rosa, R; Roviezzo, F; Saccone, I; Santagada, V; Severino, B; Temussi, PA1
Beltrán-Debón, R; Cardona, A; Castillón, S; Díaz, Y; Escudero-Casao, M; Matheu, MI1
Abegg, D; Adibekian, A; Childs-Disney, JL; Costales, MG; Disney, MD; Hoch, DG; Velagapudi, SP1

Other Studies

4 other study(ies) available for triazoles and sphingosine kinase

ArticleYear
Structure-activity relationships and molecular modeling of sphingosine kinase inhibitors.
    Journal of medicinal chemistry, 2013, Nov-27, Volume: 56, Issue:22

    Topics: Benzamides; Enzyme Inhibitors; Humans; Hydrophobic and Hydrophilic Interactions; Models, Molecular; Phosphotransferases (Alcohol Group Acceptor); Piperidines; Protein Conformation; Quaternary Ammonium Compounds; Structure-Activity Relationship; Triazoles

2013
Development of 1,2,3-Triazole-Based Sphingosine Kinase Inhibitors and Their Evaluation as Antiproliferative Agents.
    International journal of molecular sciences, 2017, Nov-05, Volume: 18, Issue:11

    Topics: Animals; Aorta; Cell Line, Tumor; Cell Proliferation; Enzyme Inhibitors; Humans; Male; Mice; Phosphotransferases (Alcohol Group Acceptor); Triazoles; Vasodilator Agents

2017
Fluorinated triazole-containing sphingosine analogues. Syntheses and in vitro evaluation as SPHK inhibitors.
    Organic & biomolecular chemistry, 2018, 10-10, Volume: 16, Issue:39

    Topics: Chemistry Techniques, Synthetic; Click Chemistry; Enzyme Inhibitors; Halogenation; Phosphotransferases (Alcohol Group Acceptor); Sphingosine; Stereoisomerism; Triazoles

2018
A Designed Small Molecule Inhibitor of a Non-Coding RNA Sensitizes HER2 Negative Cancers to Herceptin.
    Journal of the American Chemical Society, 2019, 02-20, Volume: 141, Issue:7

    Topics: Ado-Trastuzumab Emtansine; Antineoplastic Agents; Base Sequence; Benzimidazoles; Cell Line, Tumor; Drug Design; Humans; Lysophospholipids; MicroRNAs; Phosphotransferases (Alcohol Group Acceptor); Proteome; Receptor, ErbB-2; RNA Precursors; Sphingosine; Trastuzumab; Triazoles

2019